ISSUE 97 I AUGUST 2020

In association with

the route

to recovery

With a Covid-19 vaccine on the horizon, is the global supply chain up to the task of delivering it?

Genomics England: A history

Recruiting for clinical trials

Pharma vs financial crises 

Genomics England: A history

Recruiting for clinical trials

Pharma vs financial crises

02/24/2024 05:40:53
  • Home | The Route to Recovery
  • In this issue
  • Mimotopes
  • Contents
  • News
  • VEGA Company Insight
  • VEGA Australia
  • Covid-19 executive briefing by GlobalData
  • Identifying a viable Covid-19 vaccine candidate and steps needed for its successful implementation
  • Impact of Covid-19 on patients with hepatocellular carcinoma
  • NSF
  • Novavax to receive $1.6B from Operation Warp Speed for the development of Covid-
  • FDA winners and losers in Covid-19 therapies
  • Pfeiffer Vacuum
  • Trials delayed due to Covid-19 begin to resume
  • ILC Dover
  • The pharma industry briefing
  • From rare diseases to Covid-19: charting the history of Genomics England
  • Covid-19: how will pharma cope with a looming recession?
  • Pandemic logistics: guaranteeing equitable access
  • Pandemic logistics: Resolving manufacturing and distribution challenges
  • Kugelmeiers
  • Q&A: how to find the right clinical trial participants with Innovative Trials
  • Recce Pharma: a new frontier in the fight against AMR
  • Autism pipeline: are better therapies in sight?
  • How a new crystallography technique may speed up drug development
  • Psychedelics: a game-changer in mental health?
  • Graph technology: the remedy for broken supply chains is connected data
  • Deals in brief powered by GlobalData
  • The key list powered by GlobalData
  • Global markets and indices powered by GlobalData
  • Macro-economic indicators (1 of 2) powered by GlobalData
  • Macro-economic indicators (2 of 2) powered by GlobalData
  • Events
  • Next issue
07/22/2020 00:00:00